Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong
· Delayed Price · Currency is HKD 7.70
-0.23 (-2.90%)
Mar 3, 2025, 4:08 PM HKT
HKG:2096 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 19,080 | 17,611 | 30,914 | 23,628 | 23,347 | - | Upgrade
|
| Market Cap Growth | -29.50% | -43.03% | 30.83% | 1.20% | - | - | Upgrade
|
| Enterprise Value | 17,066 | 16,205 | 29,371 | 23,209 | 26,834 | - | Upgrade
|
| Last Close Price | 7.70 | 6.53 | 11.02 | 8.37 | 8.22 | - | Upgrade
|
| PE Ratio | - | 22.36 | 29.38 | 12.77 | 29.36 | - | Upgrade
|
| Forward PE | 18.14 | 11.82 | 29.04 | 26.63 | 17.99 | - | Upgrade
|
| PS Ratio | 2.91 | 2.42 | 4.32 | 3.85 | 4.36 | - | Upgrade
|
| PB Ratio | 2.63 | 2.21 | 3.83 | 2.98 | 3.68 | - | Upgrade
|
| P/TBV Ratio | 2.33 | 2.51 | 4.16 | 3.10 | 3.89 | - | Upgrade
|
| P/FCF Ratio | 28.99 | - | 27.04 | - | - | - | Upgrade
|
| P/OCF Ratio | 12.35 | 105.83 | 20.19 | - | 203.24 | - | Upgrade
|
| PEG Ratio | 1.12 | 1.12 | 1.12 | 1.12 | - | - | Upgrade
|
| EV/Sales Ratio | 2.51 | 2.23 | 4.11 | 3.78 | 5.01 | - | Upgrade
|
| EV/EBITDA Ratio | 12.83 | 15.90 | 31.86 | 44.76 | 29.79 | - | Upgrade
|
| EV/EBIT Ratio | 16.83 | 20.69 | 42.85 | 81.03 | 37.66 | - | Upgrade
|
| EV/FCF Ratio | 25.93 | - | 25.69 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.20 | 0.21 | 0.25 | 0.62 | 1.99 | Upgrade
|
| Debt / EBITDA Ratio | 0.96 | 1.43 | 1.72 | 3.50 | 4.10 | 2.26 | Upgrade
|
| Debt / FCF Ratio | 1.93 | - | 1.49 | - | - | 11.09 | Upgrade
|
| Asset Turnover | 0.52 | 0.61 | 0.60 | 0.47 | 0.51 | 0.77 | Upgrade
|
| Inventory Turnover | 1.84 | 2.84 | 4.01 | 3.59 | 2.94 | 3.14 | Upgrade
|
| Quick Ratio | 1.82 | 1.75 | 1.69 | 1.51 | 1.48 | 0.66 | Upgrade
|
| Current Ratio | 2.10 | 2.10 | 1.84 | 1.63 | 1.85 | 0.85 | Upgrade
|
| Return on Equity (ROE) | -13.81% | 9.94% | 13.62% | 25.41% | 19.49% | 65.91% | Upgrade
|
| Return on Assets (ROA) | 4.79% | 4.11% | 3.62% | 1.38% | 4.23% | 11.02% | Upgrade
|
| Return on Capital (ROIC) | 6.39% | 5.13% | 4.52% | 1.74% | 5.74% | 17.39% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.81% | 8.70% | 7.75% | 3.29% | 8.06% | 34.61% | Upgrade
|
| Earnings Yield | -6.21% | 4.47% | 3.40% | 7.83% | 3.41% | - | Upgrade
|
| FCF Yield | 3.45% | -2.08% | 3.70% | -2.14% | -1.30% | - | Upgrade
|
| Dividend Yield | 2.22% | 2.70% | 1.64% | 2.20% | 2.17% | - | Upgrade
|
| Payout Ratio | 0.00% | 58.65% | 42.04% | 25.96% | - | 90.88% | Upgrade
|
| Buyback Yield / Dilution | 1.94% | 0.45% | -0.35% | -9.14% | -2.03% | - | Upgrade
|
| Total Shareholder Return | 4.15% | 3.15% | 1.30% | -6.94% | 0.14% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.